Wordt geladen...
Placing the results of the SOLIDARITY trial with regards to remdesivir in perspective
Remdesivir, a repurposed antiviral, was first accorded approval by the US Food Drug Administration (FDA) for the treatment of COVID-19 which necessitates hospitalization. However, the interim data of SOLIDARITY trial revealed no benefits with remdesivir for COVID-19 patients which led immediate deba...
Bewaard in:
| Gepubliceerd in: | Lung India |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wolters Kluwer - Medknow
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8272424/ https://ncbi.nlm.nih.gov/pubmed/34259182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/lungindia.lungindia_883_20 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|